@article{9552d50ed9254d2c949dc8e5e031a084,
title = "Schwann cell precursors represent a neural crest-like hub state with biased multipotency",
abstract = "Schwann cell precursors (SCPs) are nerve-associated progenitors that can generate myelinating and non-myelinating Schwann cells but also are multipotent like the neural crest cells from which they originate. SCPs are omnipresent along outgrowing peripheral nerves throughout the body of vertebrate embryos. By using single-cell transcriptomics to generate a gene expression atlas of the entire neural crest lineage, we show that early SCPs and late migratory crest cells have similar transcriptional profiles characterised by a multipotent “hub” state containing cells biased towards traditional neural crest fates. SCPs keep diverging from the neural crest after being primed towards terminal Schwann cells and other fates, with different subtypes residing in distinct anatomical locations. Functional experiments using CRISPR-Cas9 loss-of-function further show that knockout of the common “hub” gene Sox8 causes defects in neural crest-derived cells along peripheral nerves by facilitating differentiation of SCPs towards sympathoadrenal fates. Finally, specific tumour populations found in melanoma, neurofibroma and neuroblastoma map to different stages of SCP/Schwann cell development. Overall, SCPs resemble migrating neural crest cells that maintain multipotency and become transcriptionally primed towards distinct lineages.",
keywords = "multipotency, neural crest, regulons, Schwann cell precursors, Schwann cell lineage",
author = "Kastriti, {Maria Eleni} and Louis Faure and {von Ahsen}, Dorothea and Bouderlique, {Thibault Gerald} and Johan Bostrom and Tatiana Solovieva and Cameron Jackson and Marianne Bronner and Dies Meijer and Saida Hadjab and Francois Lallemend and Alek Erickson and Marketa Kaucka and Viacheslav Dyachuk and Thomas Perlmann and Laura Lahti and Jan Krivanek and Jean-Francois Brunet and Kaj Fried and Igor Adameyko",
note = "Funding Information: The authors want to thank the Eukaryotic Single‐Cell Genomics facility (Stockholm, Sweden) and in particular Henrik Gezelius and Anastasios Glaros for excellent sequencing services and customer support. MEK was supported by the Novo Nordisk Foundation (Postdoc fellowship in Endocrinology and Metabolism at International Elite Environments, NNF17OC0026874) and Stiftelsen Riksbankens Jubileumsfond (Erik R{\"o}nnbergs fond stipend). LF was supported by Austrian Science Fund DOC 33‐B27. T.G.B. was supported by a Lise Meitner grant from the Austrian Science Fund (M2688‐B28). TS was supported by NIH grant DE027568 to MB. SH is supported by Swedish Research Council, Brain Foundation and StratNeuro. VD was supported by the Ministry of Science and Higher Education of the Russian Federation (Agreement No. 075‐15‐2022‐301). TP was supported by the Swedish Research Council (2020‐00884); Knut and Alice Wallenberg's Foundation and S{\"o}derberg's Foundation. IA was supported by Paradifference Foundation, The Swedish Cancer Society, Bertil H{\aa}llsten Research Foundation, Swedish Research Council, ERC Consolidator and EMBO Young Investigator Grants. Publisher Copyright: {\textcopyright}2022 The Authors.",
year = "2022",
month = jul,
day = "11",
doi = "10.15252/embj.2021108780",
language = "English",
journal = "EMBO Journal",
issn = "0261-4189",
publisher = "Wiley-Blackwell",
}